about
Nanomedicine and drug delivery strategies for treatment of inflammatory bowel diseaseRole of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice.Mechanisms underlying the effects of leukocyte apheresis with a fiber filter in a rat model of dextran sulfate sodium-induced colitis.Isolation and characterization of a novel short peptide associated with Crohn's disease.Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation.Clinical characteristics and management of gastric tube cancer with endoscopic submucosal dissectionDiagnosis of early gastric cancer using narrow band imaging and acetic acid.Dependence of intestinal granuloma formation on unique myeloid DC-like cells.A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel diseaseTherapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography.Chlamydia trachomatis proctitis.Pneumomediastinum is a frequent but minor complication during esophageal endoscopic submucosal dissection.Efficacy of peritoneovenous shunt for treating tolvaptan-resistant refractory ascites in a cirrhotic patient with portal vein thrombosis: A case report.Study to determine guidelines for pediatric colonoscopyStereomicroscopic features of colitis-associated tumors in mice: Evaluation of pit pattern.Duodenal Metastases from Lung Carcinoma.Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis.Advanced endoscopic features of ulcerative colitis-associated neoplasias: Quantification of autofluorescence imaging.Possible diagnostic role of antibodies to Crohn's disease peptide (ACP): results of a multicenter study in a Japanese cohort.Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis.Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapy.Activation of Myofibroblast TRPA1 by Steroids and Pirfenidone Ameliorates Fibrosis in Experimental Crohn's Disease.Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel disease.Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.Depletion of endothelial progenitor cells in the peripheral blood of patients with ulcerative colitis.Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channelPolyarthritis nodosa with mesenteric aneurysms demonstrated by angiography: report of a case and successful treatment of the patient with prednisolone and cyclophosphamideChronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulationDiminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresisA form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel diseasePrebiotic treatment in experimental colitis reduces the risk of colitic cancerRoles of high-mobility group box 1 in murine experimental colitisN-butyl-2-cyanoacrylate (histoacryl) glue in the right atrium after endoscopic injection for a ruptured duodenal varix: complication of histoacryl injectionAutoimmune pancreatitis presenting with IgG4-positive multiple gastric polypsSerum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patientsUlcerative colitis in a patient with non-small-cell lung cancer receiving bevacizumabMicroarray analyses of peripheral whole blood cells from ulcerative colitis patients: effects of leukocytapheresis
P50
Q26777400-F29249D3-BBC1-46E6-82A6-82408357FF8EQ30793383-409EAFCB-26F5-45C8-8E7F-38C65195C7B0Q33414704-CC08B883-B0B7-4A3C-90B5-931B9DC8B7B8Q33974071-43BC33D0-9D2E-4CA7-90AE-C0BFC47E22AFQ34726793-9CA74E1B-7E3C-47AF-90CE-7A8928175917Q34986036-B727E0C2-16D4-432C-974E-EB9CBC11701FQ35012126-5C9E39A9-436F-4D72-8906-3B88BA5A76ECQ35635502-53C9F6D9-910E-4791-B4E2-21A5D8F3F032Q36014080-D501A029-93B0-4F98-8E2D-A7E2438CBBA2Q36985561-298CD76D-F6D5-495B-A580-67B9E00EEB56Q37019308-AE4AFED5-0E81-4624-90C3-12C31F365F53Q37120022-5C3AC5DF-EDD7-4F0E-8825-5ACC24A9F89FQ37860018-050A590D-44E3-47F8-8F39-95A0D9ED4080Q40374498-4E77DC7B-B7D3-46D3-8974-343DA0702856Q40496089-9A9EEA19-690C-47DB-8C87-4CD788D7D09DQ41505624-7BB9CF4B-D1AF-48E3-974C-4EEEF8602295Q41615354-A4D9DE65-4AD7-4AF7-89E6-143B7040C1DCQ42153653-DA9324E3-866A-4F5B-ACD9-EB69F08DC653Q44453009-39C81BFB-54E9-494D-B4FA-1922BB824336Q44608371-39B142BF-ACD5-4798-856F-A768F023E37BQ46053703-7B38E60A-909C-4301-A5CE-0933F7562FE1Q46226984-1EE4CA0B-5BCE-4779-8F12-03B6BAD1ED60Q47134738-4C721009-DE1C-4F47-AC83-3FDFC4239858Q48895066-6DD8B6DF-B3E2-4E59-A9C4-216CAE1455DAQ52430882-05B46119-C086-4EAC-9117-881C7E0E9DD6Q52669034-D20892F3-BC99-45AA-A3E0-43CF6D2C9ECAQ53039139-51387E9D-CB87-4441-896D-8B1D0136A8A4Q53579498-63106E9A-106F-43FB-B2A9-5D88B43463FAQ58707775-8BF0FDEA-FB7B-4EE0-A946-DF4589F09E94Q73250194-91DCAC37-707B-430E-A722-8C6F64B05BA4Q77704355-8DC863BD-F8A3-46AE-A001-9C8D87B02F43Q81855769-84E1F419-5BE1-4E05-B98F-A8EA7013110FQ82037460-B9F881B0-D926-4848-AA81-06BFE0E563C2Q83389004-63B7E7BE-18A7-447D-AE59-ECCD2CBC4AE1Q83811387-22C4404E-85D4-4C63-ABE7-3D2EE0E50A0EQ83901690-CF2D5382-A58C-44FD-BC13-187372ADD7D1Q84759766-1AB543CD-C086-4C5C-BC45-BD2F84FB0D1CQ84963071-8FFDA1DA-74CB-46DF-8DA6-66E79ADAFCC5Q85913643-32EC1368-04F2-4290-B175-2B912F362ACBQ86102166-236B0D06-876C-43CF-A0A4-1BE614D58568
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hidetoshi Takedatsu
@ast
Hidetoshi Takedatsu
@en
Hidetoshi Takedatsu
@es
Hidetoshi Takedatsu
@nl
Hidetoshi Takedatsu
@sl
type
label
Hidetoshi Takedatsu
@ast
Hidetoshi Takedatsu
@en
Hidetoshi Takedatsu
@es
Hidetoshi Takedatsu
@nl
Hidetoshi Takedatsu
@sl
prefLabel
Hidetoshi Takedatsu
@ast
Hidetoshi Takedatsu
@en
Hidetoshi Takedatsu
@es
Hidetoshi Takedatsu
@nl
Hidetoshi Takedatsu
@sl
P106
P1153
6602095254
P21
P31
P496
0000-0002-0318-0129
P569
2000-01-01T00:00:00Z